CLDX
Price
$26.40
Change
-$0.43 (-1.60%)
Updated
Dec 26 closing price
Capitalization
1.75B
65 days until earnings call
Intraday BUY SELL Signals
CNTA
Price
$25.33
Change
-$0.35 (-1.36%)
Updated
Dec 26 closing price
Capitalization
3.74B
89 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CLDX vs CNTA

Header iconCLDX vs CNTA Comparison
Open Charts CLDX vs CNTABanner chart's image
Celldex Therapeutics
Price$26.40
Change-$0.43 (-1.60%)
Volume$356.29K
Capitalization1.75B
Centessa Pharmaceuticals
Price$25.33
Change-$0.35 (-1.36%)
Volume$465.49K
Capitalization3.74B
CLDX vs CNTA Comparison Chart in %
View a ticker or compare two or three
VS
CLDX vs. CNTA commentary
Dec 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLDX is a StrongBuy and CNTA is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 28, 2025
Stock price -- (CLDX: $26.40 vs. CNTA: $25.33)
Brand notoriety: CLDX and CNTA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CLDX: 44% vs. CNTA: 27%
Market capitalization -- CLDX: $1.75B vs. CNTA: $3.74B
CLDX [@Biotechnology] is valued at $1.75B. CNTA’s [@Biotechnology] market capitalization is $3.74B. The market cap for tickers in the [@Biotechnology] industry ranges from $117.45B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CLDX’s FA Score shows that 0 FA rating(s) are green whileCNTA’s FA Score has 0 green FA rating(s).

  • CLDX’s FA Score: 0 green, 5 red.
  • CNTA’s FA Score: 0 green, 5 red.
According to our system of comparison, CNTA is a better buy in the long-term than CLDX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CLDX’s TA Score shows that 5 TA indicator(s) are bullish while CNTA’s TA Score has 4 bullish TA indicator(s).

  • CLDX’s TA Score: 5 bullish, 5 bearish.
  • CNTA’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, CLDX is a better buy in the short-term than CNTA.

Price Growth

CLDX (@Biotechnology) experienced а +3.12% price change this week, while CNTA (@Biotechnology) price change was +1.93% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.36%. For the same industry, the average monthly price growth was +0.27%, and the average quarterly price growth was +54.56%.

Reported Earning Dates

CLDX is expected to report earnings on Mar 02, 2026.

CNTA is expected to report earnings on Mar 26, 2026.

Industries' Descriptions

@Biotechnology (+0.36% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CNTA($3.74B) has a higher market cap than CLDX($1.75B). CNTA YTD gains are higher at: 51.224 vs. CLDX (4.472). CNTA has higher annual earnings (EBITDA): -227.27M vs. CLDX (-252.86M). CLDX has more cash in the bank: 583M vs. CNTA (246M). CLDX has less debt than CNTA: CLDX (2.62M) vs CNTA (118M). CNTA has higher revenues than CLDX: CNTA (15M) vs CLDX (2.6M).
CLDXCNTACLDX / CNTA
Capitalization1.75B3.74B47%
EBITDA-252.86M-227.27M111%
Gain YTD4.47251.2249%
P/E RatioN/AN/A-
Revenue2.6M15M17%
Total Cash583M246M237%
Total Debt2.62M118M2%
FUNDAMENTALS RATINGS
CLDX: Fundamental Ratings
CLDX
OUTLOOK RATING
1..100
66
VALUATION
overvalued / fair valued / undervalued
1..100
68
Overvalued
PROFIT vs RISK RATING
1..100
91
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
48
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
38

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CLDXCNTA
RSI
ODDS (%)
Bearish Trend 2 days ago
79%
Bearish Trend 2 days ago
85%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 2 days ago
88%
Momentum
ODDS (%)
Bearish Trend 2 days ago
72%
Bearish Trend 2 days ago
86%
MACD
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
88%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
87%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
87%
Advances
ODDS (%)
Bullish Trend 6 days ago
81%
Bullish Trend 23 days ago
84%
Declines
ODDS (%)
Bearish Trend 10 days ago
78%
Bearish Trend 10 days ago
83%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
81%
Bullish Trend 2 days ago
86%
Aroon
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
CLDX
Daily Signal:
Gain/Loss:
CNTA
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
STITX7.700.02
+0.26%
Virtus SGA International Growth I
EPSYX24.890.03
+0.12%
NYLI Epoch Global Equity Yield Class I
PABYX17.110.01
+0.06%
Putnam Dynamic Asset Allocation Bal Y
VICCX20.24-0.01
-0.05%
USA Mutuals Vice C
OMGCX22.58-0.05
-0.22%
JPMorgan Mid Cap Growth C

CLDX and

Correlation & Price change

A.I.dvisor indicates that over the last year, CLDX has been loosely correlated with BEAM. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if CLDX jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CLDX
1D Price
Change %
CLDX100%
-1.60%
BEAM - CLDX
55%
Loosely correlated
-0.57%
XNCR - CLDX
55%
Loosely correlated
-1.49%
VRDN - CLDX
54%
Loosely correlated
-1.24%
RVMD - CLDX
54%
Loosely correlated
-0.54%
KURA - CLDX
54%
Loosely correlated
-3.89%
More

CNTA and

Correlation & Price change

A.I.dvisor indicates that over the last year, CNTA has been loosely correlated with CLDX. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if CNTA jumps, then CLDX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CNTA
1D Price
Change %
CNTA100%
-1.36%
CLDX - CNTA
44%
Loosely correlated
-1.60%
VRDN - CNTA
43%
Loosely correlated
-1.24%
CGON - CNTA
43%
Loosely correlated
-0.75%
DNTH - CNTA
41%
Loosely correlated
-3.06%
RVMD - CNTA
40%
Loosely correlated
-0.54%
More